Participations à des congrès et colloques internationaux (33)
  1. 15. Amighi, K., & Goole, J. (2010). Potential application of gastro-retentive dosage forms in the treatment of Parkinson disease. Paper session presented at European Modified Release Forum (21-22 Avril 2010: Londres, UK).
  2. 16. Pilcer, G., Goole, J., Van Gansbeke, B., bloklet, D., Knoop, C., Vanderbist, F., & Amighi, K. (2009). In vivo evaluation of new tobramycin dry powder formulations in cystic fibrosis patients. Poster présenté à la conférence 9ième journée des doctorants.
  3. 17. Goole, J. (2009). Etudes des caractéristiques moléculaires et fonctionnelles des transporteurs peptidiques humains. Paper session presented at Séminaire de l’école Doctorale (23 février 2009: ULB, Bruxelles, Belgique).
  4. 18. Goole, J., Deleuze, P., Vanderbist, F., & Amighi, K. (2008). Development of new L-Dopa sustained-release multiple-unit floating system coated with insoluble acrylic polymer. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology Abstract session presented at (Barcelona)
  5. 19. Lindley, D. J., Goole, J., Carl, S. M., & Knipp, G. T. (2008). Establishment of a hPepT1-stably transfected human cell line: characterization of transporter expression and function. Poster présenté à la conférence AAPS Annual Meeting and Exposition.
  6. 20. Carl, S. M., Lindley, D. J., Goole, J., & Knipp, G. T. (2008). Intracellular localization of human peptide/histidine transporter 1 (hPHT1) in the human gastrointestinal adenocarcinoma cell line HT-29. Poster présenté à la conférence AAPS Annual Meeting and Exposition.
  7. 21. Goole, J., Deleuze, P., Vanderbist, F., & Amighi, K. (2008). Development of new L-Dopa sustained release multiple-unit floating system coated with insoluble acrylic polymer. Poster présenté à la conférence 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
  8. 22. Carl, S. M., Lindley, D. J., Goole, J., & Knipp, G. T. (2008). Proton-dependent oligopeptide transporter (POT)-mediated uptake in the novel blood-brain barrier cell line, hCMEC/D3. Poster présenté à la conférence AAPS Annual Meeting and Exposition.
  9. 23. Goole, J., Vanderbist, F., & Amighi, K. (2008). Evaluation and floating enhancement of L-Dopa sustained-release floating minitablets coated with Eudragit® RL30D. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology Abstract session presented at (Barcelona)
  10. 24. Goole, J., Vanderbist, F., & Amighi, K. (2008). Evaluation and floating enhancement of L-Dopa sustained release floating minitablets coated with Eudragit RL30D. Poster présenté à la conférence 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (7th-10th April 2008: Barcelona, Spain).
  11. 25. Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new floating levodopa sustained release minitablets. 34th Annual meeting & Exposition of the Controlled Release Society Abstract session presented at 34th Annual meeting & Exposition of the Controlled Release Society(Long Beach, USA)
  12. 26. Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new multiple-unit sustained-release floating systems. Société Belge des Sciences Pharmaceutiques Abstract session presented at (Spa)
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>